Screener
Organogenesis Holdings Inc. ORGO Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s total equity?
- Organogenesis Holdings Inc. (ORGO) reported total equity of $148.27M in Q2 2026.
- How has Organogenesis Holdings Inc.'s total equity changed year-over-year?
- Organogenesis Holdings Inc.'s total equity decreased by 36.4% year-over-year, from $233.24M to $148.27M.
- What is the long-term trend for Organogenesis Holdings Inc.'s total equity?
- Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s total equity has grown at a 16.2% compound annual growth rate (CAGR), from $141.81M to $300.13M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Organogenesis Holdings Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude